Get our Newsletter
Sign up to receive the Pet Perspective, a monthly e-newsletter filled with videos and articles about pet health and other fun topics.
This is a partially-funded study for dogs with B-cell lymphoma, to assess the efficacy of a clinical device that injects microdoses of different cancer drugs or combinations of drugs into the patient’s own lymph node. The lymph node is subsequently surgically removed and analyzed microscopically for response to individual chemotherapeutic agents.
After sponsor-funded immunophenotype confirmation of B-cell lymphoma, subsequent diagnostics, procedures and surgical removal of a lymph node are funded. Additionally, the sponsor covers up to $1,000 for approved chemotherapy for B-cell lymphoma.
To qualify, dogs must meet these criteria:
For more information or to enroll your client and patient in this study, please contact: